Theresa Gaffney, the lead Morning Rounds writer at STAT, provides valuable insights on health care, new research, and public policy. With a particular focus on mental health, gender-affirming care, and LGBTQ+ patient communities, Theresa’s expertise shines through in her reporting. You can easily connect with Theresa on Signal at theresagaff.97.
As the Olympics come to a close, one standout moment that continues to resonate is Alysa Liu’s captivating free skate performance. Her graceful movements and exuberant energy, especially in the final moments of her routine, left a lasting impression on viewers worldwide.
In the realm of drug development, the landscape is evolving under the Trump administration. While the FDA has traditionally operated independently from political influence, recent shifts have seen drugmakers adapting their strategies to align with the current administration’s priorities. Lobbyists are now emphasizing the importance of building relationships with top officials to navigate the regulatory landscape effectively.
The COVID-19 pandemic has underscored the critical role of the FDA in ensuring the safety and efficacy of treatments and vaccines. Amidst this backdrop, drugmakers are facing new challenges in navigating the regulatory environment while balancing political considerations.
For more in-depth analysis and exclusive content on this topic, readers can access the full article on STAT+ subscription. By subscribing to STAT+, you can unlock premium content, newsletters, and news alerts to stay informed on the latest developments in healthcare and pharmaceuticals.
Stay tuned for more updates on health and medicine by signing up for STAT’s free newsletter, Morning Rounds, to receive your daily dose of essential information on weekdays. Join the conversation and stay informed about the latest trends in healthcare and research.
